FMO5 and diabetic kidney disease: Since oxidative and inflammatory coupling seems strongest in diabetic nephropathy, interventional studies should investigate whether targeted antioxidant or anti-inflammatory treatments (such as NADPH oxidase inhibitors, Nrf2 activators, or advanced glycation end-product (AGE) pathway modulators) can break this feedback loop before permanent renal fibrosis occurs.